by Denise Purdie Andrews | Sep 5, 2023 | Announcements, Drug Classes
By George S. Behonick, Ph.D., F-ABFT, Laboratory Director, Chief Toxicologist Synthetic compounds designed to mimic the pharmacology of various illegal drug classes infiltrated the illicit drug market during the last decade plus; this includes synthetic cannabinoids...
by Denise Purdie Andrews | Aug 18, 2023 | Announcements, Drug Classes
By Kevin Shanks, M.S., D-ABFT-FT Novel psychoactive substances (NPS) are compounds designed or consumed to mimic the effects of typical recreational substances such as diacetylmorphine (heroin), cocaine, methamphetamine, cannabis, or even prescription medications. As...
by Denise Purdie Andrews | Jul 7, 2023 | Announcements, Drug Classes
Dear Valued Client, In the spirit of continuous improvement, to provide the most relevant panels and tests in the industry, our products are periodically updated to provide new and relevant offerings. It is with that goal in mind that we announce an update to our...
by Denise Purdie Andrews | Apr 4, 2023 | Announcements
By Denise Purdie Andrews Recent industry news has been consumed with xylazine as the latest drug adulterant on the streets. Axis, your leading toxicology partner, has been testing for xylazine for several years and is prepared to assist you with questions about it...
by Denise Purdie Andrews | Jan 31, 2023 | Announcements
Dear Valued Client, In the spirit of continual improvement, to provide the most relevant panels and tests in the industry, our products are periodically updated as new compounds emerge and older compounds cease to be relevant over the years. It is with that goal in...
by Denise Purdie Andrews | Oct 4, 2022 | Announcements
By Denise Purdie Andrews This Fall, Axis’ expert toxicologists can be found speaking in several different venues, helping to educate our clients and share expertise with other forensic scientists. Last month, George S. Behonick, PhD, presented at the Indiana...
